During the past decade, NO-Tromsø-NORTHNOORWEGEN conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "NO-Tromsø-NORTHNOORWEGEN"
#1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator and "European Myeloma Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at NO-Tromsø-NORTHNOORWEGEN
According to Clinical.Site data, the most researched conditions in "NO-Tromsø-NORTHNOORWEGEN" are
"Acute Myeloid Leukemia" (2 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "NO-Tromsø-NORTHNOORWEGEN" in a lesser frequency.
Clinical Trials Intervention Types at NO-Tromsø-NORTHNOORWEGEN
Most popular intervention types in "NO-Tromsø-NORTHNOORWEGEN" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "AG-120" (1 trials), "AG-221" (1 trials) and "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NO-Tromsø-NORTHNOORWEGEN
The vast majority of trials in "NO-Tromsø-NORTHNOORWEGEN" are
3 trials for "All" genders.
Clinical Trials Status at NO-Tromsø-NORTHNOORWEGEN
Currently, there are NaN active trials in "NO-Tromsø-NORTHNOORWEGEN".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in NO-Tromsø-NORTHNOORWEGEN,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NO-Tromsø-NORTHNOORWEGEN, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".